Form 4 · LLY
Eli Lilly CEO David A. Ricks reports a gift of 23,538 shares
Part of a grouped insider digest: see all related filings with totals →
David A. Ricks, Eli Lilly's President, Chair, and CEO, a director, filed a Form 4 on Nov 4, 2026 at 4:17 PM ET reporting transactions on Nov 3, 2026.
The filing reports 23,538 shares given as a gift (code G).
After these transactions, the filing lists about 555,278 shares held directly.
Effect on holdings
Taken together, the rows reported here lowered David A. Ricks's directly held shares by 4.1%, from about 578,816 to about 555,278.
Reporting person
- David A. Ricks, President, Chair, and CEO, a director (as filed: Ricks David A)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-03 | G | Common Stock | 23,538 | Disposed | 555,278 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 4, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Last updated
- Nov 4, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.